Blog
RSS FeedPosted by Michael Wonder on 22 Mar 2021
EU has 'absolutely no need' of Russia's Sputnik V vaccine, commissioner says
21 March 2021 - The European Union does not need Russia's Sputnik V vaccine for Covid-19 and can achieve immunity ...
Posted by Michael Wonder on 18 Mar 2021
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
18 March 2021 - EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people ...
Posted by Michael Wonder on 17 Mar 2021
Europe’s vaccine suspension may be driven as much by politics as science
16 March 2021 - Once it became clear Germany was pausing, the pressure mounted on other governments to hold off as ...
Posted by Michael Wonder on 17 Mar 2021
We are in the crisis of the century’: Europe threatens to seize AstraZeneca factories
18 March 2021 - Europe has threatened to seize AstraZeneca factories and strip the pharmaceutical giant of its intellectual property ...
Posted by Michael Wonder on 16 Mar 2021
AstraZeneca vaccine fears may be more deadly than any side effect
16 March 2021 - In Europe, vaccination against COVID-19 is off to a worryingly slow start. Just 11 doses for every ...
Posted by Michael Wonder on 16 Mar 2021
Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
16 March 2021 - EMA’s safety committee (PRAC) made further progress today in its detailed evaluation of cases of blood clots, ...
Posted by Michael Wonder on 15 Mar 2021
Multiple countries pause AstraZeneca vaccine use
16 March 2021 - Germany, France and Italy are the latest countries to have suspended the AstraZeneca vaccine over blood clotting ...
Posted by Michael Wonder on 15 Mar 2021
EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events
15 March 2021 - Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 Vaccine ...
Posted by Michael Wonder on 11 Mar 2021
COVID-19 vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks
11 March 2021 - The EMA is aware that the Danish Health Authority has paused its vaccination campaign with COVID-19 ...
Posted by Michael Wonder on 11 Mar 2021
EMA recommends COVID-19 vaccine Janssen for authorisation in the EU
11 March 2021 - EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine Janssen to prevent COVID-19 in ...
Posted by Michael Wonder on 11 Mar 2021
EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesemivab for COVID-19
11 March 2021 - EMA’s CHMP has started a ‘rolling review’ of data on the antibodies bamlanivimab and etesemivab which are ...
Posted by Michael Wonder on 10 Mar 2021
Developers of Russian Sputnik V vaccine doubt EU regulator's neutrality, want apology
9 March 2021 - The developers of Russia’s Sputnik V vaccine against COVID-19 on Tuesday questioned the EMA's neutrality, after ...
Posted by Michael Wonder on 04 Mar 2021
EMA starts rolling review of the Sputnik V COVID-19 vaccine
4 March 2021 - EMA’s CHMP has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine developed by Russia’s ...
Posted by Michael Wonder on 02 Mar 2021
EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine
2 March 2021 - Openness and transparency are key to building confidence in COVID-19 vaccines. Today, EMA and Health Canada ...
Posted by Michael Wonder on 25 Feb 2021
Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers
25 February 2021 - EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in ...